ALS Research Briefs: News from 2012 AAN Conference

ALS Research Briefs: News from 2012 AAN Conference

News about the C9ORF72 gene, National ALS Registry and Cytokinetics' experimental drug was reported at the 2012 American Academy of Neurology meeting

MDA 2012 Clinical Conference Report: ALS Best Practices

MDA 2012 Clinical Conference Report: ALS Best Practices

'Best practices' for treating amyotrophic lateral sclerosis (ALS) were among the presentations at MDA’s 2012 Clinical Conference, held in March

ALS Research Briefs: SOD1, Repeat Expansions

ALS Research Briefs: SOD1, Repeat Expansions

ALS research news items on findings related to SOD1 in noninherited ALS, toxic SOD1 in ALS-affected tissue, and NIPA1 repeat expansions in ALS

Neuralstem Phase 1 Stem Cell Trial Shows Safety, Possible Efficacy

Neuralstem Phase 1 Stem Cell Trial Shows Safety, Possible Efficacy

Transplantation of stem cells into the spinal cords of 12 people with ALS has proven safe and well-tolerated, with no long-term complications

ALS TDI Webinar: TDI 132 Project Overview

ALS TDI Webinar: TDI 132 Project Overview

A webinar hosted by ALS TDI reviews the biotech's development of TDI 132 (Gilenya), a drug that modulates the immune system      

Cover Story
Commemorating its 20th year of exhibiting the works of artists with neuromuscular disease, the Muscular Dystrophy Association Art Collection continues to demonstrate that physical disability is no bar...
Featured Articles
Note: The research news featured in Research Roundup is a compilation of MDA ALS News Online articles posted between issues of the print magazine.  The following online articles were...
ALS doesn’t just affect the person with the disease — it has a profound impact on those who care about that person, too. On MDA’s website during May, an interactive feature, "ALS: It's My Story, Too...
Preventing, halting or reversing motor neuron damage is a primary goal of ALS research. But new ways of thinking about the disease are guiding scientists down different roads to that destination. MDA...

myMuscleTeam

Feedback Form
Feedback Analytics